Skip to main content
Log in

Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effect of two different doses of nitrendipine on plasma digoxin levels, urinary recovery and systolic time intervals was investigated in 8 healthy volunteers. Following a loading dose, digoxin 0.25 mg b.d. p.o. was given alone for 2 weeks. Then 0.25 mg digoxin b.d. was administered for two 1-week periods combined with nitrendipine 10 mg or 20 mg once daily. The study was completed with another digoxin monotherapy phase lasting 7 days. Nitrendipine 20 mg daily led to a significant increase in plasma digoxin levels and in its area under the plasma concentration-time curve AUC (0–12) compared to digoxin monotherapy. The AUC (0–12) was 9.7 ng ml−1h when digoxin alone was given and 11.2 ng ml−1h on co-administration of the calcium antagonist. Urinary recovery and renal clearance of digoxin were slightly but not significantly increased by nitrendipine. Nitrendipine 10 mg once daily caused a small, insignificant tendency to elevate the plasma digoxin level. Nitrendipine co-administration (10 and 20 mg once daily) did not significantly alter systolic time intervals, as non-invasively measured haemodynamic parameters, compared to digoxin treatment alone. Thus, nitrendipine 20 mg daily caused a significant increase in plasma digoxin concentrations and in its AUC, which would rarely be of clinical relevance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Belz GG, Aust PE, Doering W, Heinz M, Schneider B (1982a) Pharmacodynamics of a single dose of quinidine during chronic digoxin treatment — a randomized double blind placebo and sparteine controlled crossover study. Eur J Clin Pharmacol 22: 112–117

    Google Scholar 

  2. Belz GG, Doering W, Munkes R, Matthews J (1983) Interaction between digoxin and calcium antagonists and antiarrhythmic drugs. Clin Pharmacol Ther 33: 410–417

    Google Scholar 

  3. Belz GG, Doering W, Aust PE, Heinz M, Matthews J, Schneider B (1982b) Quinidine-digoxin interaction: cardiac efficacy of elevated serum digoxin concentration. Clin Pharmacol Ther 31: 548–554

    Google Scholar 

  4. Belz GG, Wistuba S, Matthews JH (1986) Digoxin and bepridil: Pharmacokinetic and pharmacodynamic interactions. Clin Pharmacol Ther 39: 65–71

    Google Scholar 

  5. Erbel R, Belz GG (1977) Untersuchungen zur Meßmethode der systolischen Zeitintervalle. Z Kardiol 66: 433–435

    Google Scholar 

  6. Kirch W, Hutt HJ, Heidemann H, Rämsch K, Janisch HD, Ohnhaus EE (1984) Drug interactions with nitrendipine. J Cardiovasc Pharmacol 6 [Suppl 7]: S982-S985

    Google Scholar 

  7. Kirch W, Hutt HJ, Dylewicz P, Gräf KJ, Ohnhaus EE (1986a) Dose dependence of the nifedipine/digoxin interaction? Clin Pharmacol Ther 39: 35–39

    Google Scholar 

  8. Kirch W, Stenzel J, Dylewicz P, Hutt HJ, Santos SR, Ohnhaus EE (1986b) Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin. Br J Clin Pharmacol 22: 155–159

    Google Scholar 

  9. Kirch W, Ohnhaus EE, Dylewicz P, Pabst J, Storstein L (1986) Bioavailability and elimination of digitoxin in patients with hepatorenal insufficiency. Am Heart J 111: 325–329

    Google Scholar 

  10. Kleinbloessem CH, Brummelen van P, Hillers J, Moolenaar AJ, Breimer DD (1985) Interaction between digoxin and nifedipine at steady-state in patients with atrial fibrillation. Ther Drug Monit 7: 372–376

    Google Scholar 

  11. Kuhlmann J (1985) Effects of nifedipine and diltiazem on levels and renal excretion of beta-acetyldigoxin. Clin Pharmacol Ther 37: 150–156

    Google Scholar 

  12. Oesterle SN, Schroeder JS (1982) Calcium-entry blockade, beta-adrenergic blockade and the reflex control of circulation. Circulation 65: 669–670

    Google Scholar 

  13. Pedersen KE, Dorph-Pedersen A, Hvidt S, Klitgaard NA, Kjaer K, Nielson-Kudski F (1981) Effect of nifedipine on digoxin kinetics in healthy subjects. Clin Pharmacol Ther 32: 562–565

    Google Scholar 

  14. Robson RH, Vishwanath MC (1982) Nifedipine and beta-blockade as a cause of cardiac failure. Br Med J 284: 104

    Google Scholar 

  15. Sachs L (1983) Angewandte Statistik, 6th edn, Springer, Berlin Heidelberg New York

    Google Scholar 

  16. Schäfer SG, Schuhmann G, Doering W, Fichtl B (1985) Influence of quinidine on the intestinal secretion of digoxin and digitoxin in guinea pigs. Chem Biol Interact 55: 203–213

    Google Scholar 

  17. Schwartz JB, Migliore PJ (1984) Effect of nifedipine on serum digoxin concentration and renal digoxin clearance. Clin Pharmacol Ther 36: 19–24

    Google Scholar 

  18. Walsh RA, Badke ER, O'Rourke RA (1981) Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogs. Am Heart J 102: 341–350

    Google Scholar 

  19. Weissler AM, Harris WS, Schoenfeld CD (1968) Systolic time intervals in heart failure in man. Circulation 37: 149–159

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirch, W., Logemann, C., Heidemann, H. et al. Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals. Eur J Clin Pharmacol 31, 391–395 (1986). https://doi.org/10.1007/BF00613512

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00613512

Key words

Navigation